NetworkNewsBreaks – Cytokinetics Inc. (NASDAQ: CYTK) Featured in Mizuho Securities Research Report
Cytokinetics (NASDAQ: CYTK) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Last night I had the opportunity to catch up with Cytokinetics (CEO & IR) on CK-274's upcoming Ph2 REDWOOD-HCM readout, expected mid-2021 (we believe in July). I worked through the common, more recent bear cases that investors are citing and have led to recent pressure on the stock and on which folks generally are looking for some clarity, in addition to several other common questions I'm getting.” To request access to the full report, visit http://nnw.fm/SaZ9d About Cytokinetics Cytokinetics is…







